Internal Medicine, Nephrology · Merced, CA
NPI
1467496505
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1140 Olivewood Dr
Merced, CA, 95348
Phone (209) 725-2121
Groups this clinician bills Medicare through
Medicare paid, 2024
$404K
6,828 services
Medicare patients, 2024
733
Average age 75
Drug cost, 2024
$1.6M
2,637 prescriptions
Company payments, 2025
$367
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Atul T Roy was code 90960 (esrd related services (not dialysis)), 622 times for 88 patients. In total Atul T Roy billed 6,828 services in 54 codes, and Medicare paid $404K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-11-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90960 ESRD Related Services (not dialysis) | Office | 622 | 88 | $274.62 | $171K |
| 99214 Office E&M - Established | Office | 469 | 289 | $58.28 | $27K |
| 36415 Venipuncture Blood Collection | Office | 422 | 228 | $8.65 | $3,650 |
| 84100 Clinical Chemistry | Office | 412 | 226 | $4.65 | $1,916 |
| 80053 Clinical Chemistry | Office | 411 | 226 | $10.35 | $4,254 |
| 83735 Clinical Chemistry | Office | 405 | 224 | $6.57 | $2,661 |
| 99213 Office E&M - Established | Office | 374 | 275 | $53.02 | $20K |
| 82043 Clinical Chemistry | Office | 362 | 212 | $5.66 | $2,049 |
| 82570 Clinical Chemistry | Office | 361 | 211 | $5.08 | $1,834 |
| 99233 Hospital E&M - Subsequent | Facility | 307 | 111 | $91.45 | $28K |
| 85027 Blood Count | Office | 287 | 182 | $6.34 | $1,820 |
| 99232 Hospital E&M - Subsequent | Facility | 243 | 99 | $61.54 | $15K |
| 82610 Clinical Chemistry | Office | 241 | 167 | $18.15 | $4,374 |
| 83970 Clinical Chemistry | Office | 232 | 154 | $40.45 | $9,384 |
| 82306 Clinical Chemistry | Office | 226 | 158 | $29.01 | $6,556 |
By year: 2022 $510K for 7,203 services; 2023 $495K for 7,695 services; 2024 $404K for 6,828 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 422 | 228 | $8.65 | $3,650 |
| 84100 Clinical Chemistry | 412 | 226 | $4.65 | $1,916 |
| 80053 Clinical Chemistry | 411 | 226 | $10.35 | $4,254 |
| 83735 Clinical Chemistry | 405 | 224 | $6.57 | $2,661 |
| 82043 Clinical Chemistry | 362 | 212 | $5.66 | $2,049 |
| 82570 Clinical Chemistry | 361 | 211 | $5.08 | $1,834 |
| 85027 Blood Count | 287 | 182 | $6.34 | $1,820 |
| 82610 Clinical Chemistry | 241 | 167 | $18.15 | $4,374 |
| 83970 Clinical Chemistry | 232 | 154 | $40.45 | $9,384 |
| 82306 Clinical Chemistry | 226 | 158 | $29.01 | $6,556 |
Medicare prescription drug claims, 2024
In 2024, the drug Atul T Roy prescribed most often to Medicare patients was Xphozah (Tenapanor Hcl), with 200 prescriptions and refills. In total Atul T Roy wrote 2,637 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xphozah Tenapanor Hcl | 200 | 228 | 31 | $602K |
| Losartan Potassium Generic | 194 | 570 | 68 | $1,832 |
| Jardiance Empagliflozin | 185 | 463 | 71 | $257K |
| Farxiga Dapagliflozin Propanediol | 180 | 383 | 57 | $207K |
| Amlodipine Besylate Generic | 138 | 369 | 52 | $865 |
| Prosol Parenteral Amino Acid 20% No.1 | 123 | 123 | Under 11 | $19K |
| Lisinopril Generic | 94 | 254 | 39 | $798 |
| Hydralazine Hcl Generic | 87 | 206 | 32 | $1,512 |
| Sevelamer Carbonate Generic | 85 | 206 | 34 | $31K |
| Calcium Acetate Generic | 72 | 177 | 32 | $12K |
| Atorvastatin Calcium Generic | 66 | 182 | 30 | $594 |
| Furosemide Generic | 59 | 149 | 21 | $338 |
| Calcitriol Generic | 53 | 158 | 19 | $1,414 |
| Carvedilol Generic | 52 | 152 | 25 | $470 |
| Kerendia Finerenone | 51 | 115 | 12 | $73K |
Brand drugs: - claims; generic drugs: 1,648 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Atul T Roy $367 ($367 in general payments such as food, travel and fees) from 6 companies. The largest payer was Novo Nordisk Inc with $148.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.